Cargando…

A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma

Recently, there have been reports of what could be a new lymphoproliferative entity: breast implant-associated Epstein–Barr virus positive (EBV+) diffuse large B-cell lymphoma (EBV+ BIA-DLBCL). The new World Health Organization classification has categorized it as fibrin-associated large B-cell lymp...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin de Bustamante, Jose Manuel, Mendoza, Ana, López-Muñoz, Samuel, García-Fernández, Eugenia, Gómez-Prieto, Pilar, Jiménez-Yuste, Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253260/
https://www.ncbi.nlm.nih.gov/pubmed/37297811
http://dx.doi.org/10.3390/jcm12113614
_version_ 1785056363463835648
author Martin de Bustamante, Jose Manuel
Mendoza, Ana
López-Muñoz, Samuel
García-Fernández, Eugenia
Gómez-Prieto, Pilar
Jiménez-Yuste, Victor
author_facet Martin de Bustamante, Jose Manuel
Mendoza, Ana
López-Muñoz, Samuel
García-Fernández, Eugenia
Gómez-Prieto, Pilar
Jiménez-Yuste, Victor
author_sort Martin de Bustamante, Jose Manuel
collection PubMed
description Recently, there have been reports of what could be a new lymphoproliferative entity: breast implant-associated Epstein–Barr virus positive (EBV+) diffuse large B-cell lymphoma (EBV+ BIA-DLBCL). The new World Health Organization classification has categorized it as fibrin-associated large B-cell lymphomas (FA-LBCLs); therefore, it could be referred to as breast implant-associated fibrin-associated large B-cell lymphomas (BIA-FA-LBCLs). Although the association between breast implants and lymphomas has been known since the mid-1990s, it has been almost exclusively breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Here, we describe the first case of BIA-FA-LBCL at our center, with a literature review of the clinical features, diagnosis and treatment approach of this lymphoma. We also explore the differential diagnosis of BIA-FA-LBCL, highlighting the diagnostic challenges and the reasons that have led these lymphomas to being labeled as a new face of FA-LBCL.
format Online
Article
Text
id pubmed-10253260
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102532602023-06-10 A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma Martin de Bustamante, Jose Manuel Mendoza, Ana López-Muñoz, Samuel García-Fernández, Eugenia Gómez-Prieto, Pilar Jiménez-Yuste, Victor J Clin Med Review Recently, there have been reports of what could be a new lymphoproliferative entity: breast implant-associated Epstein–Barr virus positive (EBV+) diffuse large B-cell lymphoma (EBV+ BIA-DLBCL). The new World Health Organization classification has categorized it as fibrin-associated large B-cell lymphomas (FA-LBCLs); therefore, it could be referred to as breast implant-associated fibrin-associated large B-cell lymphomas (BIA-FA-LBCLs). Although the association between breast implants and lymphomas has been known since the mid-1990s, it has been almost exclusively breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Here, we describe the first case of BIA-FA-LBCL at our center, with a literature review of the clinical features, diagnosis and treatment approach of this lymphoma. We also explore the differential diagnosis of BIA-FA-LBCL, highlighting the diagnostic challenges and the reasons that have led these lymphomas to being labeled as a new face of FA-LBCL. MDPI 2023-05-23 /pmc/articles/PMC10253260/ /pubmed/37297811 http://dx.doi.org/10.3390/jcm12113614 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Martin de Bustamante, Jose Manuel
Mendoza, Ana
López-Muñoz, Samuel
García-Fernández, Eugenia
Gómez-Prieto, Pilar
Jiménez-Yuste, Victor
A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma
title A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma
title_full A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma
title_fullStr A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma
title_full_unstemmed A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma
title_short A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma
title_sort new face of fibrin-associated large b-cell lymphoma: epstein–barr virus-positive breast implant-associated diffuse large b-cell lymphoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253260/
https://www.ncbi.nlm.nih.gov/pubmed/37297811
http://dx.doi.org/10.3390/jcm12113614
work_keys_str_mv AT martindebustamantejosemanuel anewfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma
AT mendozaana anewfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma
AT lopezmunozsamuel anewfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma
AT garciafernandezeugenia anewfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma
AT gomezprietopilar anewfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma
AT jimenezyustevictor anewfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma
AT martindebustamantejosemanuel newfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma
AT mendozaana newfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma
AT lopezmunozsamuel newfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma
AT garciafernandezeugenia newfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma
AT gomezprietopilar newfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma
AT jimenezyustevictor newfaceoffibrinassociatedlargebcelllymphomaepsteinbarrviruspositivebreastimplantassociateddiffuselargebcelllymphoma